Prevalence of Abnormal AST (n = 2)
| First Author . | Country . | Ages (y) . | N . | Subgroup (eg, M/F) . | Definition of Abnormal . | Total . | Healthy . | Overweight . | Class I . | Class II . | Class III . | P . | Notes . | Weight Definitions . | Population Info . |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Salvatore | US | 3–18 | 101 | >46 | 0 | 13.3 | 31.0 | 11.8 | .099 | Pediatric endocrinology patients | |||||
| Booth | Australia | 14–17 | 496 | Males | >33 U/L | 7.2 | 4.3 | 11.5 | 26.3 | ||||||
| Females | >26 U/L | 4.9 | 4.2 | 9.7 | 0.0 |
| First Author . | Country . | Ages (y) . | N . | Subgroup (eg, M/F) . | Definition of Abnormal . | Total . | Healthy . | Overweight . | Class I . | Class II . | Class III . | P . | Notes . | Weight Definitions . | Population Info . |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Salvatore | US | 3–18 | 101 | >46 | 0 | 13.3 | 31.0 | 11.8 | .099 | Pediatric endocrinology patients | |||||
| Booth | Australia | 14–17 | 496 | Males | >33 U/L | 7.2 | 4.3 | 11.5 | 26.3 | ||||||
| Females | >26 U/L | 4.9 | 4.2 | 9.7 | 0.0 |